Science for Regeneration

Specialist in matrix therapy for regenerative medicine

Transforming matrix therapy from research to patients.

We are a biotechnology company developing medical devices based on tissue regeneration. Our matrix therapies improve the lives of patients suffering particularly from dermatological or neurological disorders.

The RGTA® Technology

Our technology, based on ReGeneraTing Agents (RGTA®), helps to restore the cellular micro-environment to maximize tissue regeneration..

Our Research & Development

OTR3 is a biotechnology company with a strong focus on the development of matrix therapy. The quality of our research is recognized by the. European Commission (through H2020 SME instruments), by the French National Research Agency (ANR) and by the Ile de France region through multiple ongoing research and development programs.

Our commercial Activity

ISO 13485 certified, OTR3 internationally markets products as medical devices for humans and veterinary comfort products (Europe, South America, North America, the Middle East and Asia).

The latest news

Don’t miss any OTR3 news !

Questions about OTR3 ?